Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynecol Pathol Retrieve available abstracts of 125 articles: HTML format

Single Articles

March 2024
1. HAN R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al
   HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.
   Int J Gynecol Pathol. 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.
   PubMed     Abstract available
   
   
   
2. XU J, McGregor SM, Park KJ, Weisman PS, et al
   Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
   Int J Gynecol Pathol. 2024;43:145-148.
   PubMed    
   
   
   
3. BHARDWAJ S, Banet N, Gaston EC
   Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
   Int J Gynecol Pathol. 2024;43:140-144.
   PubMed     Abstract available
   
   
   
4. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
   HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
   Int J Gynecol Pathol. 2024;43:134-139.
   PubMed     Abstract available
   
   
   
5. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
   Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
   Int J Gynecol Pathol. 2024;43:123-133.
   PubMed     Abstract available
   
   
   
6. KANG EY, Terzic T, Ghatage P, Woo L, et al
   TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
   Int J Gynecol Pathol. 2024;43:111-122.
   PubMed     Abstract available
   
   
   January 2024
7. FISCHER EG
   Two Rare Cases of Paratubal Leydig Cell Nodules: Clinical Relevance and Debated Terminology of a Noteworthy Incidentaloma.
   Int J Gynecol Pathol. 2024;43:97-101.
   PubMed     Abstract available
   
   
   
8. ISE K, Tanei ZI, Oda Y, Tanikawa S, et al
   A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
   Int J Gynecol Pathol. 2024;43:41-46.
   PubMed     Abstract available
   
   
   
9. WESSMAN S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, et al
   FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
   Int J Gynecol Pathol. 2024;43:78-89.
   PubMed     Abstract available
   
   
   
10. KAWAGUCHI R, Maehana T, Sugimoto S, Kawahara N, et al
    Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
    Int J Gynecol Pathol. 2024;43:25-32.
    PubMed     Abstract available
    
    
    
11. XU J, Park KJ, Weisman PS
    An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.
    Int J Gynecol Pathol. 2024;43:67-69.
    PubMed    
    
    
    
12. ELMUTI L, Amundson J, Oberman E, Kamat A, et al
    Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
    Int J Gynecol Pathol. 2024;43:90-96.
    PubMed     Abstract available
    
    
    
13. WEPY C, Nucci MR, Parra-Herran C
    Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
    Int J Gynecol Pathol. 2024;43:70-77.
    PubMed     Abstract available
    
    
    November 2023
14. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    PubMed     Abstract available
    
    
    
15. MATSUMOTO N, Manrai P, Rottmann D, Wu X, et al
    Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:567-575.
    PubMed     Abstract available
    
    
    
16. ALNA'IRAT M, McCluggage WG, Al-Hussaini M
    Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:627-631.
    PubMed     Abstract available
    
    
    
17. STOLNICU S, Bartalis RJ, Ye Q, Da Cruz Paula A, et al
    Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.
    Int J Gynecol Pathol. 2023;42:620-626.
    PubMed     Abstract available
    
    
    
18. LIN LH, Zamuco RD, Shukla PS
    Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Int J Gynecol Pathol. 2023;42:602-612.
    PubMed     Abstract available
    
    
    October 2023
19. BICER E, Bese T, Tuzun DD, Ilvan S, et al
    The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
    Int J Gynecol Pathol. 2023 Oct 4. doi: 10.1097/PGP.0000000000000968.
    PubMed     Abstract available
    
    
    September 2023
20. KEANE E, Floyd R, McDonnell C, Beirne JP, et al
    Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Cha
    Int J Gynecol Pathol. 2023;42:466-471.
    PubMed     Abstract available
    
    
    
21. DYHDALO KS, Ababneh E, Lanigan C, Bowers K, et al
    Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:443-450.
    PubMed     Abstract available
    
    
    
22. KEYHANIAN K, Yang EJ, Howitt BE
    Nuclear beta-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2023;42:435-442.
    PubMed     Abstract available
    
    
    
23. TALIA KL, Ratnayake G, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.
    Int J Gynecol Pathol. 2023;42:496-499.
    PubMed     Abstract available
    
    
    
24. DONTHI D, Chen H, Peng Y, Niu S, et al
    Ovarian Microcystic Stromal Tumor With Intraovarian Recurrence and Peritoneal and Omental Spread: A Case Report With Morphological, Immunohistochemical, and Molecular Analysis.
    Int J Gynecol Pathol. 2023;42:491-495.
    PubMed     Abstract available
    
    
    
25. CHIESA-VOTTERO AG
    Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
    Int J Gynecol Pathol. 2023;42:514.
    PubMed    
    
    
    
26. GUERRIERI C, Hudacko R, Anderson P
    Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
    Int J Gynecol Pathol. 2023;42:500-507.
    PubMed     Abstract available
    
    
    
27. CHUI MH, Murali R, Soslow RA, Matrai C, et al
    Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
    Int J Gynecol Pathol. 2023;42:472-481.
    PubMed     Abstract available
    
    
    
28. ANDRADE LALA, Alame M, Truffaux N, Croce S, et al
    Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report of a Unique Case.
    Int J Gynecol Pathol. 2023;42:508-513.
    PubMed     Abstract available
    
    
    July 2023
29. CHUI MH, Grisham RN
    Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
    Int J Gynecol Pathol. 2023;42:432-433.
    PubMed    
    
    
    
30. TALHOUK A, Jamieson A, Crosbie EJ, Taylor A, et al
    Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
    Int J Gynecol Pathol. 2023;42:353-363.
    PubMed     Abstract available
    
    
    
31. BRAUN A, Reddy S, Cheng L, Gattuso P, et al
    Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
    Int J Gynecol Pathol. 2023;42:414-420.
    PubMed     Abstract available
    
    
    
32. HALL KC, Post MD, Alldredge J, Aisner DL, et al
    Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Int J Gynecol Pathol. 2023;42:403-413.
    PubMed     Abstract available
    
    
    
33. KOSTELECKY N, Ozhegov E, Cao D, Krigman H, et al
    Metastatic Cholangiocarcinoma to the Uterus Morphologically Imitating Primary Intestinal-type Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2023;42:398-402.
    PubMed     Abstract available
    
    
    
34. LAU JCC, McCluggage WG, Yuen LYP, Shing MMK, et al
    DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
    Int J Gynecol Pathol. 2023;42:421-425.
    PubMed     Abstract available
    
    
    
35. SUN Y, Liu-Jarin X, Hamele-Bena D, Murty VV, et al
    Ovarian Malignant Mixed Germ Cell Tumor With Prominent Embryoid Bodies (Polyembryoma Background): A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:426-431.
    PubMed     Abstract available
    
    
    May 2023
36. STRICKLAND AL, Maniar KP, Tanner E, Shanes E, et al
    Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor.
    Int J Gynecol Pathol. 2023;42:241-246.
    PubMed     Abstract available
    
    
    
37. YOSHIDA H, Uno M, Ogimoto K, Kobayashi-Kato M, et al
    Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Int J Gynecol Pathol. 2023;42:308-314.
    PubMed     Abstract available
    
    
    
38. OMO-OGBOI AC, Deavers MT, Schmeler KM, Tandon N, et al
    Collision Tumor of the Ovary Involving Sertoli-Leydig Cell Tumor and High-Grade Serous Carcinoma-Report of the First Case.
    Int J Gynecol Pathol. 2023;42:254-258.
    PubMed     Abstract available
    
    
    
39. MENDOZA R, Kertowidjojo E
    CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
    Int J Gynecol Pathol. 2023;42:325-326.
    PubMed    
    
    
    
40. HALLING GC, Udager AM, Skala SL
    Endometrial, Ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
    Int J Gynecol Pathol. 2023;42:247-253.
    PubMed     Abstract available
    
    
    March 2023
41. DEVINS KM, Zukerberg L, Watkins JC, Hung YP, et al
    BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma.
    Int J Gynecol Pathol. 2023;42:159-166.
    PubMed     Abstract available
    
    
    
42. MCHENRY A, Buza N
    Anastomosing Hemangioma of the Ovary With Leydig Cell Hyperplasia: A Clinicopathologic Study of 12 Cases.
    Int J Gynecol Pathol. 2023;42:167-175.
    PubMed     Abstract available
    
    
    
43. NILFOROUSHAN N, Liu L, Finkelman BS, Andersen J, et al
    Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
    Int J Gynecol Pathol. 2023;42:182-191.
    PubMed     Abstract available
    
    
    
44. DUNDAR B, Alrwashdeh A, Dahmoush L
    Tumor to Tumor Metastasis: A Case Report of Metastatic Angiosarcoma to an Ovarian Brenner Tumor and Review of the Literature.
    Int J Gynecol Pathol. 2023;42:176-181.
    PubMed     Abstract available
    
    
    
45. BANET N, Masnick M, Quddus MR
    Evaluation of Saccharomyces cerevisiae -like 1 (SEC14L1) in Gynecologic Malignancies Shows Overexpression in Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2023;42:136-142.
    PubMed     Abstract available
    
    
    January 2023
46. COPPOCK JD, Gradecki SE, Mills AM
    PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall.
    Int J Gynecol Pathol. 2023;42:35-42.
    PubMed     Abstract available
    
    
    
47. KOUCHI Y, Komatsu S, Harada S, Shinomiya Y, et al
    Ovarian Malignant Mixed Germ Cell Tumor Composed Mainly of a Polyembryoma Pattern With Vasculogenic Mesenchymal Tumor Components.
    Int J Gynecol Pathol. 2023;42:78-82.
    PubMed     Abstract available
    
    
    
48. ALBRIGHT BB, Wignall E, Bentley RC, Havrilesky LJ, et al
    BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord-Stromal Tumor.
    Int J Gynecol Pathol. 2023;42:83-88.
    PubMed     Abstract available
    
    
    
49. TALIA KL, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferations: A Rare Incidental Finding Associated With Endometriosis and Ovarian Epithelial Neoplasia.
    Int J Gynecol Pathol. 2023;42:70-77.
    PubMed     Abstract available
    
    
    
50. HAAG JG, Wolsky RJ, Moroney MR, Sheren J, et al
    Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2023;42:43-53.
    PubMed     Abstract available
    
    
    
51. CHANG CS, Carney ME, Killeen JL
    Two Cases of Mesonephric-like Carcinoma Arising From Endometriosis: Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2023;42:101-107.
    PubMed     Abstract available
    
    
    
52. ARCIUOLO D, Travaglino A, Santoro A, Roberti P, et al
    Pilomatrix-like High-grade Endometrioid Carcinoma is a Morphologically and Immunophenotypically Distinct Entity and May Show Mismatch Repair Deficiency.
    Int J Gynecol Pathol. 2023;42:68-69.
    PubMed    
    
    
    
53. GREGORY-DAVIS KJ, Walker A, Colello LS, McKinnon W, et al
    Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report.
    Int J Gynecol Pathol. 2023;42:89-92.
    PubMed     Abstract available
    
    
    
54. MCMULLEN-TABRY ER, Sciallis AP, Udager AM, Skala SL, et al
    Unusual Ovarian Tumors With Endometrioid Proliferations Co-Expressing Estrogen Receptor and CDX-2 Arising in Cystadenofibromatous Background: Report of 3 Cases.
    Int J Gynecol Pathol. 2023;42:93-100.
    PubMed     Abstract available
    
    
    
55. SHARMA AE, Moran A, Somasegar S, Steinhardt G, et al
    Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study.
    Int J Gynecol Pathol. 2023;42:26-34.
    PubMed     Abstract available
    
    
    
56. YIN X, Wang M, He H, Ru G, et al
    Uterine Tumor Resembling Ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-NCOA2 Fusion: Case Report With a Brief Review.
    Int J Gynecol Pathol. 2023;42:54-62.
    PubMed     Abstract available
    
    
    November 2022
57. GILL SJ, Pirzada A, Power P, Neveu J, et al
    A Constellation of Rare Gynecological Malignancies and Familial Adenomatous Polyposis Gastrointestinal Adenocarcinoma: A Case Report.
    Int J Gynecol Pathol. 2022;41:622-627.
    PubMed     Abstract available
    
    
    
58. ARCIUOLO D, Travaglino A, Santoro A, Pedone Anchora L, et al
    Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:583-587.
    PubMed     Abstract available
    
    
    
59. SAUER MA, Coy S, Quade BJ, Nucci MR, et al
    Well-developed Cerebellum in an Ovarian Mature Teratoma From a Pregnant Female.
    Int J Gynecol Pathol. 2022;41:615-621.
    PubMed     Abstract available
    
    
    
60. DEVEREAUX KA, Steiner DF, Ho C, Gomez AJ, et al
    A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:541-551.
    PubMed     Abstract available
    
    
    
61. DAHOUD W, Handler J, Parimi V, Meyer CF, et al
    Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.
    Int J Gynecol Pathol. 2022;41:600-607.
    PubMed     Abstract available
    
    
    July 2022
62. AKBARZADEH-JAHROMI M, Aslani FS, Raeisi H, Momtahan M, et al
    Comparison of Frozen and Permanent Section Diagnosis in Ovarian Neoplasms: Analysis of Factors Affecting Accuracy.
    Int J Gynecol Pathol. 2022;41:327-336.
    PubMed     Abstract available
    
    
    
63. SHETTY D, Bhalekar S, Rao S, Mukharji S, et al
    Cystic Ovarian Mucinous Carcinoma With Carcinosarcomatous Mural Nodules: An Uncommon Entity.
    Int J Gynecol Pathol. 2022;41:343-348.
    PubMed     Abstract available
    
    
    
64. MCCLUGGAGE WG, Fu L, Mohler K, de Kock L, et al
    An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.
    Int J Gynecol Pathol. 2022;41:349-355.
    PubMed     Abstract available
    
    
    
65. MATSON DR, Accola MA, Henderson L, Shao X, et al
    A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.
    Int J Gynecol Pathol. 2022;41:378-388.
    PubMed     Abstract available
    
    
    
66. LU B, Shi H, Shao Y, Xu J, et al
    Ovarian Metastasis by Gastric-type Endocervical Adenocarcinoma: A Clinicopathologic Description of 12 Cases.
    Int J Gynecol Pathol. 2022;41:356-365.
    PubMed     Abstract available
    
    
    
67. GUIDO LP, Camacho F, Freire R, Pinto A, et al
    Unusual Variants of Teratoma Involving the Gynecologic Tract.
    Int J Gynecol Pathol. 2022;41:320-326.
    PubMed     Abstract available
    
    
    
68. PARRA-HERRAN C
    Endometrioid Tubal Intraepithelial Neoplasia and Bilateral Ovarian Microcystic Stromal Tumors Harboring APC Mutations: Report of a Case.
    Int J Gynecol Pathol. 2022;41:337-342.
    PubMed     Abstract available
    
    
    May 2022
69. MATRAI CE, Ohara K, Eng KW, Glynn SM, et al
    Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence.
    Int J Gynecol Pathol. 2022;41:207-219.
    PubMed     Abstract available
    
    
    
70. PETERS EEM, Leon-Castillo A, Hogdall E, Boennelycke M, et al
    Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
    Int J Gynecol Pathol. 2022;41:227-234.
    PubMed     Abstract available
    
    
    
71. MCMULLEN ER, Huang T, Skala SL
    Large Ovarian Follicle Cyst: Benign Mimic of Cystic Adult Granulosa Cell Tumor.
    Int J Gynecol Pathol. 2022;41:289-291.
    PubMed     Abstract available
    
    
    
72. MCGINN B, Lemaire AS, McCluggage WG
    Ovarian Low-grade Basaloid Carcinoma Arising in Brenner Tumor: A New Variant of Malignant Brenner Tumor.
    Int J Gynecol Pathol. 2022;41:276-284.
    PubMed     Abstract available
    
    
    March 2022
73. GANESAN R, Gilks CB, Soslow RA, McCluggage WG, et al
    Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2022;41:142-150.
    PubMed     Abstract available
    
    
    
74. WEISMAN P, Park KJ, Xu J
    FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant beta-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Int J Gynecol Pathol. 2022;41:126-131.
    PubMed     Abstract available
    
    
    
75. RAJENDRAN S, McCluggage WG
    WT1 Positive Ovarian Endometrioid Tumors: Observations From Consult Cases and Strategies for Distinguishing From Serous Neoplasms.
    Int J Gynecol Pathol. 2022;41:191-202.
    PubMed     Abstract available
    
    
    
76. CAGAANAN A, Stelter B, Vu N, Rhode EN, et al
    HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2022;41:132-141.
    PubMed     Abstract available
    
    
    
77. RAJENDRAN S, Boyd C, Shah R, Stewart CJR, et al
    Bronchus-like Structures in Ovarian Teratomas: Report of a Series of a Previously Unreported Phenomenon With Potential For Misdiagnosis.
    Int J Gynecol Pathol. 2022;41:180-185.
    PubMed     Abstract available
    
    
    
78. WIEDEMEYER K, Wang L, Kang EY, Liu S, et al
    Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2022;41:168-179.
    PubMed     Abstract available
    
    
    January 2022
79. VROOBEL KM, McCluggage WG
    Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series.
    Int J Gynecol Pathol. 2022;41:76-81.
    PubMed     Abstract available
    
    
    
80. SHAH VI, Morgan SE, Kobel M, Lee CH, et al
    Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.
    Int J Gynecol Pathol. 2022;41:35-39.
    PubMed     Abstract available
    
    
    
81. WANG L, Piskorz A, Bosse T, Jimenez-Linan M, et al
    Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies.
    Int J Gynecol Pathol. 2022;41:12-19.
    PubMed     Abstract available
    
    
    
82. WATKINS JC, Young RH
    Mullerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter.
    Int J Gynecol Pathol. 2022;41:68-75.
    PubMed     Abstract available
    
    
    
83. CAO J, Hacking S, Chavarria-Bernal HD, Bhuiya TA, et al
    Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
    Int J Gynecol Pathol. 2022;41:28-34.
    PubMed     Abstract available
    
    
    November 2021
84. KWON DH, Malpica A, Zaleski M, Euscher ED, et al
    Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract.
    Int J Gynecol Pathol. 2021;40:523-532.
    PubMed     Abstract available
    
    
    
85. ABU-SINN D, Jamison J, Evans M, McCluggage WG, et al
    Pelvic and Ovarian Recurrence of Small HPV-associated Cervical Adenocarcinoma With Transformation to Neuroendocrine Carcinoma.
    Int J Gynecol Pathol. 2021;40:541-548.
    PubMed     Abstract available
    
    
    
86. JHA S, Mitra S, Patra S, Sethi P, et al
    Krukenberg Tumor of Ovary During Pregnancy: Learning From A Mistake.
    Int J Gynecol Pathol. 2021;40:617-620.
    PubMed     Abstract available
    
    
    
87. KARPATHIOU G, Chauleur C, Dal Col P, Peoc'h M, et al
    FOXA1 Expression by Immunohistochemistry in Carcinosarcomas of the Endometrium and Ovary/Fallopian Tube.
    Int J Gynecol Pathol. 2021;40:611-616.
    PubMed     Abstract available
    
    
    September 2021
88. OLIVADESE R, Ramponi A, Boldorini R, Dalla Dea G, et al
    Mitotically Active Cellular Fibroma of the Ovary Recurring After the Longest Interval of Time (16 yr): A Challenging Case With Systematic Literature Review.
    Int J Gynecol Pathol. 2021;40:441-447.
    PubMed     Abstract available
    
    
    
89. CATTEAU X, Preat F, D'haene N, Noel JC, et al
    Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report.
    Int J Gynecol Pathol. 2021;40:448-451.
    PubMed     Abstract available
    
    
    
90. NAGAR R, Peters T, Nagar H, McCluggage WG, et al
    Diagnostic Accuracy in Assessment of Depth of Myometrial Invasion in Low-grade Endometrioid Carcinoma: A 2 Center Comparative Study by MRI and Intraoperative Assessment.
    Int J Gynecol Pathol. 2021;40:495-500.
    PubMed     Abstract available
    
    
    July 2021
91. LAI J, Garvey KY, Li P, Azevedo RA, et al
    Primary Ovarian Melanoma Arising From a Mature Teratoma With Melanoma In Situ Present in the Ciliated Columnar and Squamous Epithelium in a Patient With Synchronous Skin Basal Cell Carcinoma.
    Int J Gynecol Pathol. 2021;40:383-390.
    PubMed     Abstract available
    
    
    
92. D'ANTONIO A, Caleo A, Addesso M, Caputo A, et al
    A Rare Case of Castleman Disease Presenting as an Ovarian Tumor.
    Int J Gynecol Pathol. 2021;40:379-382.
    PubMed     Abstract available
    
    
    
93. SALISBURY T, Gilks CB
    Immunoreactive Acellular Keratin in Sentinel Lymph Nodes From a Patient With Endometrioid Carcinoma of the Endometrium With Squamous Differentiation: A Case Report of a Potential Diagnostic Pitfall.
    Int J Gynecol Pathol. 2021;40:355-358.
    PubMed     Abstract available
    
    
    
94. WATKINS JC, Young RH
    Follicle Cysts of the Ovary: A Report of 30 Cases of a Common Benign Lesion Emphasizing its Unusual Clinical and Pathologic Aspects.
    Int J Gynecol Pathol. 2021;40:359-368.
    PubMed     Abstract available
    
    
    
95. HEIMBIGNER AM, Davaro EP, Schwetye K
    Benign Brenner Tumor in an Ectopic Ovary: A Case Report and Review of Literature.
    Int J Gynecol Pathol. 2021;40:376-378.
    PubMed     Abstract available
    
    
    May 2021
96. ZHANG L, Velazquez M, Wang X, Masand R, et al
    Ovarian Mixed Epithelial Carcinoma With Extensive Bilateral Fallopian Tubes Metastases by the Low-grade Serous Carcinoma Component Mimicking Serous Tubal Intraepithelial Carcinoma: Case Presentation and Literature Review.
    Int J Gynecol Pathol. 2021;40:305-309.
    PubMed     Abstract available
    
    
    
97. WRIGHT MF, Fitzlaff S, Wyeth A, Zaragoza-Watkins M, et al
    Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy.
    Int J Gynecol Pathol. 2021;40:240-247.
    PubMed     Abstract available
    
    
    
98. HODGSON A, Ghorab Z, Parra-Herran C
    Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.
    Int J Gynecol Pathol. 2021;40:296-300.
    PubMed     Abstract available
    
    
    
99. HALVORSON TS, Robinson RA, Samuelson MI
    Pure Primary Ovarian Carcinoid Tumor.
    Int J Gynecol Pathol. 2021;40:301-304.
    PubMed     Abstract available
    
    
    
100. SHARMA AE, Hamedani FS, Barroeta JE, Pytel P, et al
     Clear Cell Papillary Cystadenoma of the Ovary Masquerading as Metastatic Clear Cell Renal Cell Carcinoma: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2021;40:290-295.
     PubMed     Abstract available
     
     
     March 2021
101. LADWIG NR, Umetsu SE, Zaloudek C, Rabban J, et al
     Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
     Int J Gynecol Pathol. 2021;40:103-115.
     PubMed     Abstract available
     
     
     
102. BENNETT JA, Safdar N, Segal JP, Lastra RR, et al
     Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma.
     Int J Gynecol Pathol. 2021;40:156-164.
     PubMed     Abstract available
     
     
     
103. GUERRIERI C, Anderson P, Hudacko R
     Ciliated Carcinoma of the Endometrium.
     Int J Gynecol Pathol. 2021;40:141-147.
     PubMed     Abstract available
     
     
     
104. LIN SY, Hang JF, Lin YY, Lai CR, et al
     Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression.
     Int J Gynecol Pathol. 2021;40:148-155.
     PubMed     Abstract available
     
     
     
105. BRETT MA, Atenafu EG, Singh N, Ghatage P, et al
     Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
     Int J Gynecol Pathol. 2021;40:116-123.
     PubMed     Abstract available
     
     
     
106. KATSAKHYAN L, Baraban EG, Dumoff KL, Burger RA, et al
     The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
     Int J Gynecol Pathol. 2021;40:175-179.
     PubMed     Abstract available
     
     
     January 2021
107. KOBEL M, Kang EY
     The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
     Int J Gynecol Pathol. 2021;40:32-40.
     PubMed     Abstract available
     
     
     
108. TAYLOR J, Shah R, McElvanna K, Kelly PJ, et al
     Late Development of Metastatic Ovarian Mucinous Adenocarcinoma From Primary Gallblader Adenocarcinoma and High-grade Dysplasia.
     Int J Gynecol Pathol. 2021;40:41-48.
     PubMed     Abstract available
     
     
     
109. CRASTA J, Ravikumar G, Rajarajan S, Gali S, et al
     Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity.
     Int J Gynecol Pathol. 2021;40:49-55.
     PubMed     Abstract available
     
     
     
110. STEWART CJR, Harding S
     Stromal Endocrine Cell Micronests Associated With an Ovarian Mucinous Cystadenoma: Endocrine Cell Preservation (Pseudohyperplasia) Potentially Mimicking Stromal Sex Cord Proliferation or Tumor Microinvasion.
     Int J Gynecol Pathol. 2021;40:56-59.
     PubMed     Abstract available
     
     
     July 2020
111. FEDDA FA, Euscher ED, Ramalingam P, Malpica A, et al
     Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:313-320.
     PubMed     Abstract available
     
     
     
112. TRENTO M, Munari G, Carraro V, Lanza C, et al
     Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease.
     Int J Gynecol Pathol. 2020;39:305-312.
     PubMed     Abstract available
     
     
     
113. LENGYEL K, Young F, Kucukmetin A, Cresti N, et al
     BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:321-326.
     PubMed     Abstract available
     
     
     
114. ABBAS A, Ud Din N, Kayani N
     Synchronous Well-differentiated Endometrioid Adenocarcinoma and Leiomyosarcoma of the Uterus With Pulmonary Metastasis in a 50-Yr-Old Woman: A Case Report and Review of Literature.
     Int J Gynecol Pathol. 2020;39:373-378.
     PubMed     Abstract available
     
     
     May 2020
115. ABOZINA A, Singh N, Blake C
     Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years.
     Int J Gynecol Pathol. 2020;39:296-300.
     PubMed     Abstract available
     
     
     
116. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
     Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer?
     Int J Gynecol Pathol. 2020;39:213-220.
     PubMed     Abstract available
     
     
     
117. FAHOUM I, Brazowski E, Hershkovitz D, Aizic A, et al
     Tumor-to-Tumor Metastasis of Colorectal Adenocarcinoma to Ovarian Cystadenofibroma: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:270-272.
     PubMed     Abstract available
     
     
     
118. CHAPEL DB, Lengyel E, Ritterhouse LL, Lastra RR, et al
     Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.
     Int J Gynecol Pathol. 2020;39:233-237.
     PubMed     Abstract available
     
     
     March 2020
119. BROUWER J, Strickland KC, Ning G, Schmelkin CB, et al
     Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
     Int J Gynecol Pathol. 2020;39:163-169.
     PubMed     Abstract available
     
     
     
120. ZHANG X, Guo J, Yang L, Zhao Y, et al
     Ovarian Sclerosing Stromal Tumor and Mullerian Cyst in an 11-yr-old Girl: A Case Report and Review of the Literature.
     Int J Gynecol Pathol. 2020;39:e5-e10.
     PubMed     Abstract available
     
     
     
121. BAI S, Hutchinson LM, Meng X, Bai H, et al
     Dedifferentiated Carcinoma of the Endometrium Associated With Low-grade Mullerian Adenosarcoma: A Clinicopathologic Case Report Including the Immunohistochemical and Molecular Profile.
     Int J Gynecol Pathol. 2020;39:141-145.
     PubMed     Abstract available
     
     
     
122. VOS MC, Hollemans E, van der Steen SCHA, van Kuppevelt TH, et al
     Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma.
     Int J Gynecol Pathol. 2020;39:184-192.
     PubMed     Abstract available
     
     
     
123. COSTIGAN DC, Dong F, Nucci MR, Howitt BE, et al
     Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma.
     Int J Gynecol Pathol. 2020;39:119-127.
     PubMed     Abstract available
     
     
     
124. CHEN PH, Hui P, Buza N
     Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
     Int J Gynecol Pathol. 2020;39:193-198.
     PubMed     Abstract available
     
     
     
125. CHIESA-VOTTERO A
     CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
     Int J Gynecol Pathol. 2020;39:170-177.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.